Bank of America’s Evogene EVGN Stock Holding History

Bank of America’s Portfolio EVGN Stock Details EVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-159	Closed	-$175	–	6089
2025 Q4	$175	Hold	159	–	–	﹤0.01%	6725
2025 Q3	$182	Sell	159 -2,312	-94%	-$2.93K	﹤0.01%	7750
2025 Q2	$3.16K	Buy	2,471 +2,387	+2,842%	+$2.92K	﹤0.01%	7364
2025 Q1	$105	Buy	84 +78	+1,300%	+$118	﹤0.01%	7819
2024 Q4	$11	Sell	6 -132	-96%	-$260	﹤0.01%	8085
2024 Q3	$423	Sell	138 -501	-78%	-$2.16K	﹤0.01%	7414
2024 Q2	$4.15K	Buy	639 +532	+497%	+$3.71K	﹤0.01%	7047
2024 Q1	$806	Sell	107 -28	-21%	-$234	﹤0.01%	7230
2023 Q4	$1.13K	Sell	135 -28	-17%	-$176	﹤0.01%	7182
2023 Q3	$956	Sell	163 -3	-2%	-$26	﹤0.01%	7241
2023 Q2	$1.77K	Sell	166 -2,213	-93%	-$15K	﹤0.01%	7158
2023 Q1	$15K	Sell	2,379 -11,825	-83%	-$88K	﹤0.01%	6836
2022 Q4	$99.4K	Hold	14,204	–	–	﹤0.01%	6236
2022 Q3	$118K	Buy	14,204 +581	+4%	+$5.6K	﹤0.01%	6267
2022 Q2	$105K	Sell	13,623 -6,829	-33%	-$66.8K	﹤0.01%	6440
2022 Q1	$265K	Buy	20,452 +6,787	+50%	+$91.5K	﹤0.01%	6288
2021 Q4	$224K	Buy	13,665 +13,523	+9,523%	+$307K	﹤0.01%	6438
2021 Q3	$3K	Sell	142 -364	-72%	-$10.6K	﹤0.01%	7820
2021 Q2	$17K	Buy	506 +415	+456%	+$16.3K	﹤0.01%	7179
2021 Q1	$5K	Hold	91	–	–	﹤0.01%	7116
2020 Q4	$4K	Buy	+91	New	+$3.21K	﹤0.01%	6850
2020 Q3	–	Sell	-32,353	Closed	-$323K	–	6970
2020 Q2	$323K	Sell	32,353 -157	-0.5%	-$1.7K	﹤0.01%	4938
2020 Q1	$384K	Hold	32,510	–	–	﹤0.01%	4696
2019 Q4	$494K	Hold	32,510	–	–	﹤0.01%	5017
2019 Q3	$514K	Hold	32,510	–	–	﹤0.01%	5068
2019 Q2	$523K	Sell	32,510 -70,647	-68%	-$1.31M	﹤0.01%	5034
2019 Q1	$1.89M	Sell	103,157 -75	-0.1%	-$1.59K	﹤0.01%	4032
2018 Q4	$2.04M	Buy	103,232 +75	+0.1%	+$1.9K	﹤0.01%	3827
2018 Q3	$3.21M	Hold	103,157	–	–	﹤0.01%	3575
2018 Q2	$2.95M	Buy	103,157 +1,289	+1%	+$39.3K	﹤0.01%	3654
2018 Q1	$3.23M	Sell	101,868 -471	-0.5%	-$17.5K	﹤0.01%	3481
2017 Q4	$3.14M	Buy	102,339 +4,929	+5%	+$194K	﹤0.01%	3553
2017 Q3	$4.33M	Buy	97,410 +8,030	+9%	+$382K	﹤0.01%	3317
2017 Q2	$4.52M	Buy	89,380 +5,225	+6%	+$270K	﹤0.01%	3126
2017 Q1	$4.5M	Buy	84,155 +4,253	+5%	+$222K	﹤0.01%	3131
2016 Q4	$4.08M	Buy	79,902 +3,693	+5%	+$211K	﹤0.01%	3127
2016 Q3	$4.86M	Buy	76,209 +2,520	+3%	+$166K	﹤0.01%	2863
2016 Q2	$4.6M	Buy	73,689 +9,455	+15%	+$659K	﹤0.01%	2871
2016 Q1	$4.18M	Buy	64,234 +8,533	+15%	+$586K	﹤0.01%	2919
2015 Q4	$4.48M	Buy	55,701 +11,661	+26%	+$866K	﹤0.01%	3056
2015 Q3	$3.63M	Buy	44,040 +4,935	+13%	+$430K	﹤0.01%	3199
2015 Q2	$3.46M	Buy	39,105 +40	+0.1%	+$3.87K	﹤0.01%	2931
2015 Q1	$3.44M	Buy	39,065 +1,050	+3%	+$97.9K	﹤0.01%	2784
2014 Q4	$3.5M	Sell	38,015 -3,422	-8%	-$363K	﹤0.01%	2870
2014 Q3	$5.45M	Buy	41,437 +31	+0.1%	+$4.28K	﹤0.01%	2497
2014 Q2	$6.78M	Hold	41,406	–	–	﹤0.01%	2272
2014 Q1	$7.89M	Sell	41,406 -10,654	-20%	-$2.02M	﹤0.01%	1976
2013 Q4	$10.2M	Buy	+52,060	New	+$9.62M	﹤0.01%	1834

Other funds holding EVGN

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

DSC

Daytona Street Capital Saint Louis, Missouri $130M AUM

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Bank of America's EVGN Position: Q1 2026 in Review

Bank of America sold out of Evogene (EVGN) in Q1 2026, closing a stake of 159 shares — an estimated $175 sold.

Bank of America first reported a position in EVGN in Q4 2013 and held it in 48 quarters. The position peaked at $10.2M in Q4 2013. 15 funds tracked by Wall St. Rank hold EVGN as of Q1 2026.

Bank of America reported no remaining Evogene position as of Q1 2026 after selling out during the quarter.
Bank of America sold 159 Evogene shares in Q1 2026, an estimated $175.
Bank of America first reported a position in Evogene in Q4 2013 and held it in 48 quarters.
Bank of America's Evogene position peaked at $10.2M in Q4 2013.
15 funds tracked by Wall St. Rank held Evogene as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.